VentriPoint Diagnostics Ltd Cash Flow Conversion Efficiency
VentriPoint Diagnostics Ltd cash flow conversion efficiency. Based on the latest financial reports, VentriPoint Diagnostics Ltd (VPT) has a cash flow conversion efficiency ratio of 0.146x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-599.37K ≈ $-433.58K USD) by net assets (CA$-4.12 Million ≈ $-2.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of VentriPoint Diagnostics Ltd (2005–2025)
Cash flow conversion efficiency of VentriPoint Diagnostics Ltd from 2005 to 2025. This chart illustrates how VentriPoint Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest VentriPoint Diagnostics Ltd stock price today for real-time trading data and today's change.
VentriPoint Diagnostics Ltd Cash Flow Conversion Ratio Explained
VentriPoint Diagnostics Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
VentriPoint Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of VentriPoint Diagnostics Ltd ranked by their cash flow conversion efficiency. Also see VPT stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Admiralty Resources NL
AU:ADY
|
0.000x |
|
Pilulka Lekarny as
PR:PINK
|
N/A |
|
aXichem AB
ST:AXIC-A
|
-0.034x |
|
TwentyFour Income Fund Ltd
LSE:TFIF
|
0.015x |
|
Four Leaf Acquisition Corporation Class A Common Stock
NASDAQ:FORL
|
-0.074x |
|
i2S SA
PA:ALI2S
|
0.169x |
|
Trailbreaker Resources Ltd
V:TBK
|
-0.011x |
|
G Capital Bhd
KLSE:7676
|
0.031x |
Annual Cash Flow Conversion Efficiency for VentriPoint Diagnostics Ltd (2005–2025)
The table below shows the annual cash flow conversion efficiency of VentriPoint Diagnostics Ltd from 2005 to 2025. Review cash generation quality of VentriPoint Diagnostics Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$-4.12 Million ≈ $-2.98 Million |
CA$-1.55 Million ≈ $-1.12 Million |
0.378x | -66.74% |
| 2024-12-31 | CA$-2.98 Million ≈ $-2.16 Million |
CA$-3.39 Million ≈ $-2.45 Million |
1.136x | +105.66% |
| 2023-12-31 | CA$189.71K ≈ $137.23K |
CA$-3.80 Million ≈ $-2.75 Million |
-20.052x | -2107.17% |
| 2022-12-31 | CA$4.55 Million ≈ $3.29 Million |
CA$-4.14 Million ≈ $-2.99 Million |
-0.908x | -140.60% |
| 2021-12-31 | CA$8.33 Million ≈ $6.03 Million |
CA$-3.15 Million ≈ $-2.28 Million |
-0.378x | -180.59% |
| 2020-12-31 | CA$-2.35 Million ≈ $-1.70 Million |
CA$-1.10 Million ≈ $-795.98K |
0.469x | -51.41% |
| 2019-12-31 | CA$-2.47 Million ≈ $-1.79 Million |
CA$-2.38 Million ≈ $-1.72 Million |
0.964x | -69.22% |
| 2018-12-31 | CA$-973.26K ≈ $-704.04K |
CA$-3.05 Million ≈ $-2.21 Million |
3.133x | +65.95% |
| 2017-12-31 | CA$-1.63 Million ≈ $-1.18 Million |
CA$-3.07 Million ≈ $-2.22 Million |
1.888x | +93.11% |
| 2016-12-31 | CA$-2.25 Million ≈ $-1.63 Million |
CA$-2.20 Million ≈ $-1.59 Million |
0.978x | -83.62% |
| 2015-12-31 | CA$-269.66K ≈ $-195.07K |
CA$-1.61 Million ≈ $-1.16 Million |
5.967x | +1033.35% |
| 2014-12-31 | CA$-2.40 Million ≈ $-1.73 Million |
CA$-1.26 Million ≈ $-912.31K |
0.526x | -36.40% |
| 2013-12-31 | CA$-3.12 Million ≈ $-2.26 Million |
CA$-2.58 Million ≈ $-1.87 Million |
0.828x | -49.84% |
| 2012-12-31 | CA$-2.65 Million ≈ $-1.92 Million |
CA$-4.37 Million ≈ $-3.16 Million |
1.650x | -3.38% |
| 2011-12-31 | CA$-2.33 Million ≈ $-1.68 Million |
CA$-3.98 Million ≈ $-2.88 Million |
1.708x | -27.65% |
| 2010-12-31 | CA$-860.17K ≈ $-622.24K |
CA$-2.03 Million ≈ $-1.47 Million |
2.360x | +434.52% |
| 2009-12-31 | CA$-3.26 Million ≈ $-2.36 Million |
CA$-1.44 Million ≈ $-1.04 Million |
0.442x | -80.32% |
| 2008-12-31 | CA$-1.87 Million ≈ $-1.35 Million |
CA$-4.20 Million ≈ $-3.04 Million |
2.244x | +682.50% |
| 2007-12-31 | CA$2.50 Million ≈ $1.81 Million |
CA$-965.08K ≈ $-698.12K |
-0.385x | -590.65% |
| 2006-12-31 | CA$670.44K ≈ $484.98K |
CA$-37.40K ≈ $-27.06K |
-0.056x | -886.77% |
| 2005-12-31 | CA$695.36K ≈ $503.01K |
CA$-3.93K ≈ $-2.84K |
-0.006x | -- |
About VentriPoint Diagnostics Ltd
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional m… Read more